Country Websites

Managing an Increase in Patient Census during Flu Season

Due to a spike in hospitalizations, particularly among people 65 years and older, the demand for kidney replacement therapy peaks during flu season. This can create a real problem as hospitals struggle to treat more patients with limited availability of equipment, nurses, and supplies.

Some hospitals have overcome these challenges by using their NxStage System One for Prolonged Intermittent Kidney Replacement Therapy (PIKRT). PIKRT is a gentle1 6–12 hour therapy with similar hemodynamic, clearance, and survival outcomes to IHD and CKRT, along with greater flexibility in staffing and patient scheduling.2,3

NxStage System One S with NxView

PIKRT may help you in several ways:

Benefits to the Dialysis Unit:

If your ICU nurses are already familiar with the NxStage® System One, patients normally on IHD can be placed on PIKRT and managed by the ICU to free the Dialysis staff to care for other non-acute patients.2


Benefits to the ICU:

Get more therapies from existing equipment.4

  • For patients who might otherwise be placed on CKRT during this peak period, PIKRT may be considered as a practical alternative for patients who can tolerate a 6–12 hour therapy.1
  • By transitioning patients off of CKRT to PIKRT, more than one patient can be treated using the same machine within a 24-hour period.
  • The ICU can manage patients without relying on the availability of the Dialysis staff, who might also be dealing with an increased workload during flu season.

Contact Us For More Information

For more information on maximizing resources during flu season, complete the form below and a NxStage representative will contact you.

References:

  1. Edrees F, Li T, Vijayan A. Prolonged Intermittent Renal Replacement Therapy. Adv Chronic Kidney Dis 2016;23(3):195-202.
  2. Concepcion LA, et al. ARF requiring dialysis: use of shift CVVHD vs. conventional dialysis. J Am Soc Nephrol. 2009; Suppl, F-P01557 (Abstract).
  3. Rodby R, Vijayan A. "Roundtable Discussion of Hybrid Renal Replacement Therapies." 2017, Revision A.
  4. NxStage System One User Guide. NC4921 Rev M 2022-07.

 

© 2024 Fresenius Medical Care. All Rights Reserved. Fresenius Medical Care, the triangle logo, NxStage, System One and NxView are trademarks of Fresenius Medical Care Holdings, Inc. or its affiliated companies. All other trademarks are the property of their respective owners.

CAUTION: Federal law restricts this device to sale by or on the order of a physician.

APM2203 Rev. B